SRPT vs. ANF
Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and Abercrombie & Fitch Co. (ANF).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SRPT or ANF.
Correlation
The correlation between SRPT and ANF is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SRPT vs. ANF - Performance Comparison
Key characteristics
SRPT:
-0.79
ANF:
-0.63
SRPT:
-1.10
ANF:
-0.68
SRPT:
0.84
ANF:
0.92
SRPT:
-0.67
ANF:
-0.62
SRPT:
-1.63
ANF:
-1.24
SRPT:
29.73%
ANF:
32.49%
SRPT:
61.45%
ANF:
63.91%
SRPT:
-98.17%
ANF:
-86.59%
SRPT:
-66.19%
ANF:
-62.75%
Fundamentals
SRPT:
$5.99B
ANF:
$3.57B
SRPT:
$2.34
ANF:
$10.69
SRPT:
25.83
ANF:
6.70
SRPT:
159.25
ANF:
-24.52
SRPT:
3.15
ANF:
0.72
SRPT:
3.92
ANF:
2.67
SRPT:
$1.49B
ANF:
$4.95B
SRPT:
$1.21B
ANF:
$3.17B
SRPT:
$247.43M
ANF:
$934.53M
Returns By Period
The year-to-date returns for both stocks are quite close, with SRPT having a -50.29% return and ANF slightly lower at -52.07%. Over the past 10 years, SRPT has outperformed ANF with an annualized return of 16.68%, while ANF has yielded a comparatively lower 15.07% annualized return.
SRPT
-50.29%
-15.83%
-53.91%
-53.06%
-13.16%
16.68%
ANF
-52.07%
-7.60%
-49.38%
-41.32%
46.70%
15.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SRPT vs. ANF — Risk-Adjusted Performance Rank
SRPT
ANF
SRPT vs. ANF - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Abercrombie & Fitch Co. (ANF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SRPT vs. ANF - Dividend Comparison
Neither SRPT nor ANF has paid dividends to shareholders.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ANF Abercrombie & Fitch Co. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.98% | 4.63% | 3.99% | 4.59% | 6.67% | 2.96% | 2.79% |
Drawdowns
SRPT vs. ANF - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, which is greater than ANF's maximum drawdown of -86.59%. Use the drawdown chart below to compare losses from any high point for SRPT and ANF. For additional features, visit the drawdowns tool.
Volatility
SRPT vs. ANF - Volatility Comparison
The current volatility for Sarepta Therapeutics, Inc. (SRPT) is 25.47%, while Abercrombie & Fitch Co. (ANF) has a volatility of 27.53%. This indicates that SRPT experiences smaller price fluctuations and is considered to be less risky than ANF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SRPT vs. ANF - Financials Comparison
This section allows you to compare key financial metrics between Sarepta Therapeutics, Inc. and Abercrombie & Fitch Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities